PubMed Health⌕ Search

PubMed · 16709286

Analysing multitrait-multimethod data with structural equation models for ordinal variables applying the WLSMV estimator: what sample size is needed for valid results?

Abstract

Convergent and discriminant validity of psychological constructs can best be examined in the framework of multitrait-multimethod (MTMM) analysis. To gain information at the level of single items, MTMM models for categorical variables have to be applied. The CTC(M-1) model is presented as an example of an MTMM model for ordinal variables. Based on an empirical application of the CTC(M-1) model, a complex simulation study was conducted to examine the sample size requirements of the robust weighted least squares mean- and variance-adjusted chi(2) test of model fit (WLSMV estimator) implemented in Mplus. In particular, the simulation study analysed the chi(2) approximation, the parameter estimation bias, the standard error bias, and the reliability of the WLSMV estimator depending on the varying number of items per trait-method unit (ranging from 2 to 8) and varying sample sizes (250, 500, 750, and 1000 observations). The results showed that the WLSMV estimator provided a good -- albeit slightly liberal -- chi(2) approximation and stable and reliable parameter estimates for models of reasonable complexity (2-4 items) and small sample sizes (at least 250 observations). When more complex models with 5 or more items were analysed, larger sample sizes of at least 500 observations were needed. The most complex model with 9 trait-method units and 8 items (72 observed variables) requires sample sizes of at least 1000 observations.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Fridtjof W Nussbeck, Michael Eid, Tanja Lischetzke. 2006. Analysing multitrait-multimethod data with structural equation models for ordinal variables applying the WLSMV estimator: what sample size is needed for valid results?. https://doi.org/10.1348/000711005x67490

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗